Download PDF
Kardiologie up2date 2008; 4(4): 299-312
DOI: 10.1055/s-0028-1103440
Angeborene und erworbene Herzfehler

© Georg Thieme Verlag KG Stuttgart · New York

Herzbeteiligung bei systemischen inflammatorischen Erkrankungen

Michael  G.  Radermacher, Nico  Merkle, Ruth  H.  Strasser, Vinzenz  Hombach
Further Information

Publication History

Publication Date:
30 December 2008 (online)

Also available at
    Permissions and Reprints All articles of this category

Abstract

Systemic inflammatory diseases frequently involve the cardiovascular system, and cardiac and vascular manifestations are extremely variable. An early diagnosis of cardiac involvement is essential for the patients since in many inflammatory systemic conditions cardiac disease determines prognosis and mortality. In addition to history, electrocardiographic and echocardiographic examinations cardiac magnetic resonance imaging is particularly useful to detect morphological and functional changes as well as myocardial perfusion abnormalities and to unmask inflammatory reactions of the myocardium or quantify myocardial scars. If cardiac involvement is present the usual anti-inflammatory or immunosuppressive treatment will be completed by usual cardiac care such as cardioactive drugs, intracardiac defibrillator or pacemaker implantation.

Kernaussagen

  • Das klinische Spektrum der systemischen inflammatorischen Erkrankungen ist extrem vielfältig, eine Beteiligung des Herzens und der großen Gefäße ebenfalls äußerst variabel.

  • Das frühzeitige Erkennen einer Herzbeteiligung ist für viele Patienten von eminenter klinischer Bedeutung, da bei einer Reihe von Krankheitsbildern das Fortschreiten der kardialen Erkrankung die Prognose und die Letalität der Patienten bestimmt.

  • Die klassischen diagnostischen Werkzeuge sind die Anamnese und klinische Untersuchung, die Röntgenuntersuchung, das EKG und die Echokardiografie sowie bei speziellen Fragestellungen spezielle histologische und nuklearmedizinische Methoden.

  • Daneben kann aber der frühzeitige Einsatz der CMR-Bildgebung mit den Möglichkeiten der Beurteilung der Herzfunktion und der Myokarddurchblutung sowie der Detektion von entzündlichen und/oder narbigen Myokardveränderungen die klinische Situation und den Schweregrad klären und bei der therapeutischen Führung der Patienten eine wesentliche Hilfestellung leisten.

Literatur

  • 1 Hellemans S, Dens D, Knockaert D. Coronary involvement in the Churg-Strauss syndrome.  Heart. 1997;  77 576-578
    PubMedGoogle Scholar
  • 2 Kozak M, Gill E A, Green L S. The Churg-Strauss syndrome. A case report with angiographically documented coreonary involvement and a review of the literature.  Chest. 1995;  107 578-580
    PubMedGoogle Scholar
  • 3 Tarel el G, Yasser A E, Gheita T. Coronary angiographic findings in asymptomatic systemic sclerosis.  Clin Rheumatol. 2006;  25 487-490
    CrossrefPubMedGoogle Scholar
  • 4 Shikama N, Nakagawa T, Takiguchi Y. et al . Assessment of myocardial perfusion and fatty acid metabolism in a patient with Churg-Strauss syndrome associated with eosinophilic heart disease.  Circ J. 2004;  68 595-598
    CrossrefPubMedGoogle Scholar
  • 5 Nakajima K, Kawano M, Hasegawa M. et al . Myocardial damages in systemic sclerosis detected by gated myocardial perfusion SPECT and sympathetic imaging.  Circ J. 2006;  70 1481-1487
    CrossrefPubMedGoogle Scholar
  • 6 Gaàl J, Hegedüs I, Dévényi K, Czirják L. Myocardial gallium-67 citrate scintigraphy in patients with systemic sclerosis.  Ann Rheum Dis. 1995;  54 856-858
    CrossrefPubMedGoogle Scholar
  • 7 Terasaki F, Hayashi T, Hirota Y. et al . Evolution to dilated cardiomyopathy from eosinophilic pancarditis in Churg-Strauss syndrome.  Heart Vessels. 1997;  12 43-48
    PubMedGoogle Scholar
  • 8 Panchal L, Divate S, Vaideeswar P, Pandit S P. Cardiovascular involvement in systemic lupus erythematodes: an autopsy study of 27 patients in India.  J Postgrad Med. 2006;  52 5-10
    PubMedGoogle Scholar
  • 9 Knockaert D C. Cardiac involvment in systemic inflammatory disease.  Eur Heart J. 2007;  28 1797-1804
    CrossrefPubMedGoogle Scholar
  • 10 Guillevin L, Cohen Gauraud M, Lhote F. et al . Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients.  Medicine. 1999;  78 26-37
    CrossrefPubMedGoogle Scholar
  • 11 Sable-Fourtassou R, Cohen P, Mahr A. et al . French Vasculitis Study Group. Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome.  Ann Intern med. 2005;  143 632-638
    PubMedGoogle Scholar
  • 12 Petersen S E, Kardos A, Neubauer S. Subendocardial and papillary muscle involvment in a patient with Churg-Strauss syndrome, detected by contrast enhanced cardiovascular magnetic resonance.  Heart. 2005;  91 e9
    CrossrefPubMedGoogle Scholar
  • 13 Alter P, Maisch B. Endomyocardial fibrosis in Churg-Strauss syndrome assessed by cardiac magnetic resonance imaging.  Int J Cardiol. 2006;  108 112-113
    CrossrefPubMedGoogle Scholar
  • 14 Caudron J, Bauer F, Dacher J N. Cardiac magnetic resonance demonstrates the three-layer involvment in Churg-Strauss syndrome.  Eur Heart J. 2008;  Epub ahead of print
    PubMedGoogle Scholar
  • 15 Smedema J P, van Paassen P, van Kroonenburgh M J. et al . Cardiac involvement of Churg-Strauss syndrome demonstrated by magnetic resonance imaging.  Clin Exp Rheumatol. 2004;  22 75-78
    PubMedGoogle Scholar
  • 16 Goodfield N ER, Bhandari S, Plant W D. et al . Cardiac involvement in Wegener’s granulomatosis.  Br Heart J. 1995;  73 110-115
    PubMedGoogle Scholar
  • 17 Korantzopoulos P, Papaioannidis D, Siogas K. The heart in Wegener’s granulomatosis.  Cardiology. 2004;  102 7-10
    CrossrefPubMedGoogle Scholar
  • 18 Oliveira G H, Seward J B, Tsang T S, Specks U. Echocardiographic findings in patients with Wegener granulomatosis.  Mayo Clin Proc. 2005;  80 1435-1440
    CrossrefPubMedGoogle Scholar
  • 19 Morelli S, Gurgo Di Castelmenardo A M, Conti F. et al . Cardiac involvment in patients with Wegener’s granulomatosis.  Rheumatol Int. 2000;  19 209-212
    CrossrefPubMedGoogle Scholar
  • 20 Merkel P A, Lo G H, Holbrook J T. et al . Wegener’s Granulomatosis Etanercept trial Research Group. Brief communication: high incidence of venous therombotic events among patients with Wegener granulomatosis: the Wegener’s Clinical Occurrence of Thrombosis (WeCLOT) Study.  Ann Intern Med. 2005;  142 620-626
    CrossrefPubMedGoogle Scholar
  • 21 To A, De Zoysa J, Christiansen J P. Images in Cardiology: Cardiomyopathy associated with Wegener’s granulomatosis.  Heart. 2007;  93 984
    PubMedGoogle Scholar
  • 22 Brihaye B, Aouba A, Pagnoux C. et al . Rituximab reversed cardiac involvement of WegenerŽs granulomatosis: magnetic resonance imaging assessment.  Presse Med. 2008;  37 412-415
    CrossrefPubMedGoogle Scholar
  • 23 Bohl S, Wassmuth R, Abdel-Aty H. et al . Delayed enhancement cardiac magnetic resonance imaging reveals typical patterns of myocardial injury in patients with various forms of non-ischemic heart disease.  Int J Cardiovasc Imaging. 2008;  24 597-607
    CrossrefPubMedGoogle Scholar
  • 24 Moder K G, Miller T D, Tazelaar H D. Cardiac involvment in systemic lupus erythematodes.  Mayo Clin Proc. 1999;  74 275-284
    CrossrefPubMedGoogle Scholar
  • 25 Panchal L, Divate S, Vaideeswar P, Pandit S P. Cardiovascular involvement in systemic lupus erythematodes: an autopsy study on 27 patients in India.  J Postgrad Med. 2006;  52 5-10
    PubMedGoogle Scholar
  • 26 Roldan C A, Shively B K, Crawford M H. An echocardiographic study of valvular heart disease associated with systemic lupus eryrthematodes.  N Engl J Med. 1996;  335 1424-1430
    CrossrefPubMedGoogle Scholar
  • 27 Asanuma Y, Oeser A, Shintani A K. et al . Premature coronary-artery atherosclerosis in systemic lupus erythematosus.  N Engl J Med. 2003;  349 2407-2415
    CrossrefPubMedGoogle Scholar
  • 28 Roman M J, Shanker B A, Davis A. et al . Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus.  N Engl J Med. 2003;  349 2399-2406
    CrossrefPubMedGoogle Scholar
  • 29 Hahn B H. Systemic lupus erythematosus and accelerated atherosclerosis.  N Engl J Med. 2004;  349 2379-2380
    PubMedGoogle Scholar
  • 30 Schattner A, Liang M H. The cardiovascular burden of lupus: a complex challenge.  Arch Intern Med. 2003;  163 1507-1510
    CrossrefPubMedGoogle Scholar
  • 31 Lin C C, Ding H J, Chen Y W. et al . Usefulness of technetium-99 m sestamibi myocardial perfusion SPECT in detection of cardiovascular involvement in patients with systemic lupus erythematosus or systemic sclerosis.  Int J Cardiol. 2003;  92 157-161
    CrossrefPubMedGoogle Scholar
  • 32 Moncayo R, Kowald E, Scjauer N. et al . Detection of myocardial involvement in systemic lupus erythematosus: mismatch between normal perfusion scans with 201Thallium ajnd pathological 18FDG uptake.  Int Angiol. 2001;  20 314-321
    PubMedGoogle Scholar
  • 33 Korkmaz C, Cansu D U, Kascedilifogbrevelu T. Myocardial infarction in young patients (≤ 35 years of age) with systemic lupus erythematosus: a case report and clinical analysis of the literature.  Lupus. 2007;  16 289-297
    CrossrefPubMedGoogle Scholar
  • 34 Edwards N C, Ferro C J, Townend J N, Steeds P. Myocardial disease in systemic vasculitis and autoimmune disease detected by cardiovascular magnetic resonance. Letter to the Editor.  Rheumatology. 2007;  46 1208-1209
    CrossrefPubMedGoogle Scholar
  • 35 Abdel-Aty H, Siegle N, Natusch A. et al . Myocardial tissue characterization in systemic lupus erythematosus: value of a comprehensive cardiovascular magnetic resonance approach.  Lupus. 2008;  17 561-567
    CrossrefPubMedGoogle Scholar
  • 36 Singh T JA, Woodard P K, Dávila-Román V G. et al . Cardiac magnetic resonance imaging abnormalities in systemic lupus erythematosus: a preliminary report.  Lupus. 2005;  14 137-144
    CrossrefPubMedGoogle Scholar
  • 37 Kepez A, Akdogan A, Sade L E. et al . Detection of subclinical cardiac involvment in systemic sclerosis by echocardiographic strain imaging.  Echocardiography. 2008;  25 191-197
    CrossrefPubMedGoogle Scholar
  • 38 Lindquist P, Caidahl K, Neumann-Andersen G. et al . Disturbed right ventricular function in patients with systemic sclerosis. A Doppler Tissue study.  Chest. 2005;  128 755-763
    CrossrefPubMedGoogle Scholar
  • 39 Meune C, Avouac J, Wahbi K. et al . Cardiac involvment in systemic sclerosis assessed by tissue-doppler echocardiography during routine care: A controlled study of 100 consecutive patients.  Arthitis Rheum. 2008;  58 1803-1809
    CrossrefPubMedGoogle Scholar
  • 40 De Groote P, Gressin V, Hachulla E et al. for the ItinerAIR-Scleroderma Investigators . Evaluation of cardiac abnormalities by Doppler echocardiography in a large nationwide multicentric cohort of patients with systemic sclerosis.  Ann Rheum Dis. 2008;  67 31-36
    CrossrefPubMedGoogle Scholar
  • 41 Byers R J, Marschall D A, Freemont A J. Pericardial involvment in systemic sclerosis.  Ann Rheum Dis. 1997;  56 393-394
    CrossrefPubMedGoogle Scholar
  • 42 Ferri C, Valentini G, Cozzi F. et al . Systemic Svclerosis Study Group of the Italian Society of Rheumatology (SIR-GSSSc). Systemic sclerosis. Demographic, clinical, and serological features and survival in 1012 Italian patients.  Medicine. 2002;  81 139-153
    CrossrefPubMedGoogle Scholar
  • 43 Bezante G P, Rollando D, Sessarego M. et al . Cardiac magnetic resonance imaging detects subclinical right ventricular impairment in systemic sclerosis.  J Rheumatol. 2007;  34 2431-2437
    PubMedGoogle Scholar
  • 44 Vignaux O, Allanore Y, Meune C. et al . Evaluation of the effect of nifedipine upon myocardial perfusion and contractility using cardiac magnetic resonance imaging and tissue Doppler echocardiography in systemic sclerosis.  Ann Rheum Dis. 2005;  64 1268-1273
    CrossrefPubMedGoogle Scholar
  • 45 Allanore Y, Meune C, Vignaux O. et al . Bosentan increases myocardial perfusion and function in systemic sclerosis: a magnetic resonance imaging and Tissue-Doppler echocardiography study.  J Rheumatol. 2006;  33 2464-2469
    PubMedGoogle Scholar
  • 46 Tselepis G E, Kelekis N L, Plastiras S C. et al . Pattern and distribution of myocardial fibrosis in systemic sclerosis: a delayed enhanced magnetic resonance imaging study.  Arthritis Rheum. 2007;  56 3827-3836
    CrossrefPubMedGoogle Scholar
  • 47 McCann G P, Gan C T, Beek A M. et al . Extent of MRI delayed enhancement of myocardial mass is related to right ventricular dysfunction in pulmonary artery hypertension.  AJR Am J Roentgenol. 2007;  188 349-355
    CrossrefPubMedGoogle Scholar
  • 48 Dalakas M C, Hohlfeld R. Polymyositis and dermatomyositis.  Lancet. 2003;  362 971-982
    CrossrefPubMedGoogle Scholar
  • 49 Gonzalez-Lopez L, Gamez-Nava J I, Sanchez L. et al . Cardiac manifestations in dermato-polymyositis.  Clin Exp Rheumatol. 1996;  14 373-379
    PubMedGoogle Scholar
  • 50 Douglas W D, Tazelaar H D, Hartman T E. et al . Polymyositis-dermatomyositis-associated interstitial lung disease.  Am J Resp Crit Care Med. 2001;  164 1182-1185
    CrossrefPubMedGoogle Scholar
  • 51 Allanore Y, Vignaux O, Arnaud L. et al . Effects of corticosteroids and immunosuppressors on idiopathic inflammatory myopathy related to myocarditis evaluated by magnetic resonance imaging.  Ann Rheum Dis. 2006;  65 249-252
    CrossrefPubMedGoogle Scholar
  • 52 Guillevin L, Lhote F, Gauyraud M. et al . Prognostic factors in polyarteriitis nodosa and Churg-Strauss syndrome.  Medicine. 1996;  75 17-28
    CrossrefPubMedGoogle Scholar
  • 53 Guillevin L, Durand-Gasselin B, Cevallos R. et al . Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients.  Arthritis Rheum. 1999;  42 421-430
    CrossrefPubMedGoogle Scholar
  • 54 Agard C, Mouzthon L, Mahr A, Guillevin L. Microscopic polyangiitis and panarteriitis nodosa: how and when do they start?.  Arthitis Rheum. 2003;  49 709-715
    CrossrefPubMedGoogle Scholar
  • 55 Arnold R, Lev S, Ley-Zaporozhan J. et al . Visualization of coronary arteries in patients after childhood Kawasaki syndrome: value of multidetector CT and MR imaging in comparisaon to conventional coronary catheterization.  Pediatr Radiol. 2007;  37 998-1006
    CrossrefPubMedGoogle Scholar
  • 56 Greil G F, Seeger A, Miller S. et al . Coronary magnetic resonance angiography and vessel wall imaging in children with Kawasaki disease.  Pediatr Radiol. 2007;  37 666-673
    CrossrefPubMedGoogle Scholar
  • 57 Takemura A, Suzuki A, Inaba R. et al . Utility of coronary MR angiography in children with Kawasaki disease.  AJR Am J Radiol. 2007;  188 W534-W539
    PubMedGoogle Scholar
  • 58 Mavrogeni S, Papadopoulos G, Douskou M. et al . Magnetic resonance angiography, function and viability evaluation in patients with Kawasaki disease.  J Cardiovasc Magn Reson. 2006;  8 493-498
    CrossrefPubMedGoogle Scholar
  • 59 Gyöngyösi M, Pokorny G, Jambrik Z. et al . Cardiac manifestations in primary Sjögren’s syndrome.  Ann Rheum Dis. 1996;  55 450-454
    CrossrefPubMedGoogle Scholar
  • 60 Levin M D, Zoet-Nugteren S K, Markusse H M. Myocarditis and primary Sjögren’s syndrome.  Lancet. 1999;  354 128-129
    CrossrefPubMedGoogle Scholar
  • 61 Kural-Seyahi E, Fresko I, Seyahi N. et al . The long-term mortality and morbidity of Behçet’s syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center.  Medicine. 2003;  82 60-76
    CrossrefPubMedGoogle Scholar
  • 62 Sakane T, Takeno M, Suzuki N, Inaba G. Behçet’s disease.  N Engl J Med. 1999;  341 1284-1291
    CrossrefPubMedGoogle Scholar
  • 63 Huong D L, Wechsler B, Papo T. et al . Endomyocardial fibrosis in Behçet’s disease.  Ann Rheum Dis. 1997;  56 205-208
    CrossrefPubMedGoogle Scholar
  • 64 Albayram M S, Wityk R, Youssem D M, Zinreich S J. The cerebral angiographic findings in Cogan’s syndrome.  Am J Neuroradiol. 2001;  22 751-754
    PubMedGoogle Scholar
  • 65 Lunardi C, Bason C, Leandri M. et al . Autoantibodies to inner ear and endothelial antigens in Cogan’s syndrome.  Lancet. 2002;  360 915-921
    CrossrefPubMedGoogle Scholar
  • 66 Erb N, Sinha A, Slaney P L, Rowe I F. Acute atrioventricular node block requiring cardiac pacing in Cogan’s syndrome.  Rheumatology. 2003;  42 1126-1128
    CrossrefPubMedGoogle Scholar

Dr. med. Michael G. Radermacher

Zentrum für Innere Medizin II
Universitätsklinikum Ulm

Albert-Einstein-Allee 23
89081 Ulm

Email: Michael.Radermacher@uniklinik-ulm.de

      >